Uryash A, Wu H, Bassuk J, Kurlansky P, Sackner MA, Adams JA. Low-amplitude pulses to the circulation through periodic acceleration induces endothelial-dependent vasodilatation. J Appl Physiol 106: 1840 -1847 , 2009 . First published March 26, 2009 doi:10.1152/japplphysiol.91612.2008.-Low-amplitude pulses to the vasculature increase pulsatile shear stress to the endothelium. This activates endothelial nitric oxide (NO) synthase (eNOS) to promote NO release and endothelial-dependent vasodilatation. Descent of the dicrotic notch on the arterial pulse waveform and a-to-b ratio (a/b; where a is the height of the pulse amplitude and b is the height of the dicrotic notch above the end-diastolic level) reflects vasodilator (increased a/b) and vasoconstrictor effects (decreased a/b) due to NO level change. Periodic acceleration (pG z) (motion of the supine body head to foot on a platform) provides systemic additional pulsatile shear stress. The purpose of this study was to determine whether or not pG z applied to rats produced endothelial-dependent vasodilatation and increased NO production, and whether the latter was regulated by the Akt/phosphatidylinositol 3-kinase (PI3K) pathway. Male rats were anesthetized and instrumented, and pG z was applied. Sodium nitroprusside, N G -nitro-L-arginine methyl ester (L-NAME), and wortmannin (WM; to block Akt/PI3K pathway) were administered to compare changes in a/b and mean aortic pressure. Descent of the dicrotic notch occurred within 2 s of initiating pG z. Dose-dependent increase of a/b and decrease of mean aortic pressure took place with SNP. L-NAME produced a dose-dependent rise in mean aortic pressure and decrease of a/b, which was blunted with pG z. In the presence of WM, pGz did not decrease aortic pressure or increase a/b. WM also abolished the pG z blunting effect on blood pressure and a/b of L-NAME-treated animals. eNOS expression was increased in aortic tissue after pG z. This study indicates that addition of low-amplitude pulses to circulation through pG z produces endothelial-dependent vasodilatation due to increased NO in rats, which is mediated via activation of eNOS, in part, by the Akt/PI3K pathway. vascular resistance; N G -nitro-L-arginine methyl ester, wortmannin; nitric oxide ADDED LOW-AMPLITUDE PULSES to the vasculature were generated with periodic acceleration (pG z ). pG z is produced by a motorized platform that repetitively moves the horizontally oriented body sinusoidally in a head to foot direction. Inertia of fluid as the body accelerates and decelerates adds a small-amplitude pulse to the circulation that is superimposed on the natural pulse, increasing pulsatile shear stress to the endothelium (3, 6, 7). In large-animal models, increased pulsatile shear stress activates endothelial nitric oxide (NO) synthase (eNOS) to release NO into the circulation, which, in turn, induces endothelial-dependent pulmonary and systemic vasodilatation, as well as increasing organ blood flows (3, 5, 6) . pG z applied to anesthetized swine increases serum nitrite, which is a qualitative marker for the release of NO (4, 44) . pG z leads to a phosphorylation of eNOS that is correlated with a phosphorylation of Akt in endothelial cells (48). The release of NO into the circulation with pG z has been shown to be physiologically meaningful and long lasting in a sheep model of asthma (1). Additionally, pG z applied to human subjects increases brachial flow-mediated vasodilation and induces release of NO, which is comparable to light to moderate exercise (36, 47).
well as increasing organ blood flows (3, 5, 6) . pG z applied to anesthetized swine increases serum nitrite, which is a qualitative marker for the release of NO (4, 44) . pG z leads to a phosphorylation of eNOS that is correlated with a phosphorylation of Akt in endothelial cells (48) . The release of NO into the circulation with pG z has been shown to be physiologically meaningful and long lasting in a sheep model of asthma (1) . Additionally, pG z applied to human subjects increases brachial flow-mediated vasodilation and induces release of NO, which is comparable to light to moderate exercise (36, 47) .
Because NO synthesized by eNOS is metabolized within 4 s, NO cannot be measured directly in the bloodstream. Instead, serum nitrite, a metabolite, is measured as a qualitative marker of NO release. The same increased values of serum nitrite in the nanomole range that occur with increased shear stress during flow-mediated dilation or aerobic exercise do not produce immediate vasodilatation when infused into the circulation at such concentrations in humans (30, 44, 47) . Therefore, in this investigation, we relied on the vasodilator properties of NO to assess effectiveness of pG z . It has long been recognized that nitrates produce descent of the dicrotic notch on the descending limb of the digital pulse waveform of humans (13) . This phenomenon is attributed to vasodilatation of the resistance vessels, thereby lengthening the arterial pulse wave reflection time (26) . In humans, descent of the dicrotic notch of digital and aortic pulse waves has been observed with nitrate and albuterol administration, as well as with exercise (10, 26, 29, 39, 42, 46) . This finding is mediated through the action of NO, since inhibition of NO synthesis with N G -nitro-L-arginine methyl ester (L-NAME) or N G -monomethyl-L-arginine prevents descent of the dicrotic notch after acetylcholine or albuterol administration in rabbits and humans, respectively (26, 52) .
Our purpose was to assess whether pG z applied to rats serves as a means of producing endothelial-dependent vasodilatation and to test whether such an effect is mediated, in part, via the well-known shear stress induced Akt/phosphatidylinositol 3-kinase (PI3K) pathway for NO production (13, 55, 57) .
MATERIALS AND METHODS

Animal Preparation
These studies were approved by the Mount Sinai Medical Center Institutional Animal Care and Use Committee and comply with the Animal Welfare Act.
Albino rats (n ϭ 60), weighing between 300 and 320 g (Charles River Laboratories, Wilmington, MA), were anesthetized with intramuscular ketamine (60 mg/kg)/xylazine (10 mg/kg) until a surgical plane of anesthesia was obtained and supplemented throughout the experiment, along with support doses as necessary. A tracheotomy was performed, and a 14G endotracheal tube inserted. A size 2F Millar Mikro-Tip pressure catheter was inserted into the right carotid artery to measure ascending aortic pressure and dicrotic notch position (Millar Instruments, Houston, TX). The a-to-b ratio (a/b) was computed from the aortic pressure pulse, where a is the height of the pulse amplitude divided by b, the height of the dicrotic notch above the end-diastolic level. An increase of the a/b signifies vasodilatation, and a decrease vasoconstriction. A 24-gauge catheter was placed into the tail vein for administration of fluids and drugs.
The animals were maintained at 38°C with a thermostatically controlled warming pad. The animals were placed on the motion platform in the supine position with the front and hind legs taped securely to the table and the rat's body closely coupled to the platform. The tracheotomy tube was connected to a small-animal mechanical ventilator delivering inspired O 2 fraction of 0.21 (model CIV-101, Columbus Instruments, Columbus, OH). This was set to 70 -75 breaths/min with tidal volumes of 4.0 -4.5 ml, such that arterial PCO 2 was maintained at ϳ38 Torr. Animals did not exhibit spontaneous respirations while on the ventilator. pG z was applied with a platform that was moved with a linear displacement direct-current motor (model 400, 12 V; APS Dynamics, Carlsbad, CA), powered by a dual-mode power amplifier (model 144, APS Dynamics), connected to a sine wave controller (model 140 -072; NIMS, Miami, FL). The controller allows control of frequency and travel distance of the platform with a read-out of acceleration from an accelerometer. The platform has a maximum weight capacity of 30 kg, operates at a frequency from 30 -720 cycles/min (cpm), and achieves accelerations ranging from Ϯ0.1 to Ϯ14.7 m/s 2 . The animals were secured to the platform, and Gz was continuously monitored during application of pGz. The lead II electrocardiogram (ECG) was continuously monitored from a standard three-lead configuration. The analog signals from the transducers, accelerometer, and ECG were continuously recorded on a data-acquisition processor (Power Lab, AD Instruments) at a rate of 400 samples/s.
Experimental Design
Aortic pressure and a/b changes. After surgical preparation, the anesthetized rats were connected to a mechanical ventilator. Baseline (BL) measurements of hemodynamic parameters were obtained on all animals. In the first group of animals (n ϭ 6), 12.5 g/kg of sodium nitroprusside (SNP) was administered through the tail vein. A second group of animals (n ϭ 24) received L-NAME (Sigma Chemicals, St. Louis, MO) infused into the tail vein over a 10-min period, for a total cumulative dose of 6 mg/kg. A third group of rats (n ϭ 24) was subjected to 30 min of pGz at frequencies of 180, 360, and 600 cpm, with a peak acceleration amplitude of Ϯ2.9 m/s 2 . The aortic pressure and ECG were recorded at BL, during and after drug infusions, and continuously during pGz. The a/b were computed for 30 s at the end of each period of BL, pGz, L-NAME, and SNP recordings. The following values were computed: 1) mean heart rate (HR), 2) mean aortic pressure, and 3) mean a/b. The dicrotic notch position was readily identified on the aortic pressure wave. A 20-beat ensemble average was applied to the aortic pressure wave to obtain the mean a/b.
eNOS. eNOS was determined in aortic samples from three untreated rats and three rats exposed to 1 h of pGz at a frequency of 360 cpm, which appeared to produce the highest degree of vasodilation among the frequencies tested. The aortas were homogenized in lysis buffer (50 mM potassium phosphate buffer containing 1% Triton X-100, protease inhibitor cocktail, 4 mM EDTA, pH 7.2). After 30 min of incubation, the homogenate was centrifuged at 12,000 g for 10 min. The supernatant was collected, and the protein concentration was determined using bicinchoninic acid method. An equal amount of protein was loaded and separated on SDS-PAGE and transferred to nitrocellulose membrane. The nitrocellulose membrane was blocked with buffer [Tris-NaCl buffer containing 3% (wt/vol) dry milk and 0.1% Tween 20, pH 7.2], probed with anti-eNOS antibody, and then incubated with horseradish peroxidase-conjugated secondary antibody. The protein of interest was visualized using an enhanced chemiluminescence kit. The level of actin was used as loading control. The image acquired was analyzed using Image J 1.36b (National Institutes of Health).
Effects of pGz on L-NAME and comparison to SNP. Cumulative dose-response curves in terms of the a/b and mean aortic pressure were obtained from intravenous administration of L-NAME (Sigma Chemical) with different frequencies of pG z. Animals were randomized to pGz of 180, 360, and 600 cpm (experimental groups) with Gz Ϯ 2.9 m/s 2 held constant. Rats either were subjected to one frequency for 30 min (pGz-30 min) or were placed on a platform for the same time period without applying pG z (control). L-NAME (n ϭ 24) was infused into the tail vein over a 10-min period to produce cumulative doses of 0.5, 1, 2.5, 4, 5, and 6 mg/kg. In another group of animals, SNP (n ϭ 6) was continuously infused through a light protected tail vein with cumulative doses of 0.5, 2.5, and 12.5 g/kg.
The following were calculated for 30 s at the end of each period of BL, pG z, L-NAME, or SNP infusion: 1) mean HR, 2) mean aortic pressure, and 3) mean a/b.
Effects of wortmannin on pG z and effect of pGz on L-NAME in presence of wortmannin. To assess the contribution of the shear stress-induced pathway Akt/PI3K on the pG z-induced, endothelialdependent vasodilation, wortmannin (WM), a specific inhibitor of PI3K, was used. Cumulative dose-response curves in terms of the a/b and mean aortic pressure were obtained from intravenous administration of WM, with and without pG z. Animals were randomized to WM (15 g/kg) and pGz of 360 cpm (experimental groups, n ϭ 6) with a Gz Ϯ 2.9 m/s 2 held constant and the same dose of WM without pGz (control group, n ϭ 6). Four rats were also injected with L-NAME (4 mg/kg) after WM and pG z (WM/pGz/L-NAME group).
Statistical Analysis
Statistical analysis of the data was accomplished with software running on a personal computer (InStat, GraphPad Software, La Jolla, CA). Results were expressed as mean percent (%) to BL with SD, and comparison of means with 95% confidence levels was carried out using ANOVA, followed by post hoc analysis with the NewmanKeuls test. Significance between means was taken as P Ͻ 0.05.
RESULTS
Effects of pG z , L-NAME, and SNP on Mean Aortic Pressure, HR, and Aortic Pressure Wave
Mean HR and mean arterial pressure (MAP) did not significantly differ among groups at BL. pG z at all frequencies tested did not produce a significant change in HR compared with BL values. Mean HR at BL in controls and pG z of 180, 360, and 600 cpm were 315 (SD 8), 314 (SD 11), 315 (SD 17), and 314 beats/min (SD 20), respectively (P ϭ nonsignificant). The application of pG z at all frequencies decreased MAP within 5 min of its application, but the a/b increased ϳ25-50% from BL within 2 s. MAP progressively decreased during 30 min after pG z . pG z of 180 cpm administration decreased MAP from BL of 111 (SD 7) to 98 mmHg (SD 6) (P Ͻ 0.05). Similarly, 360-and 600-cpm pG z produced a decrease in MAP from 112 (SD 6) to 71 mmHg (SD 11) (360-cpm pG z ) and 112 (SD 3) to 85 mmHg (SD 5) (600-cpm pG z ) at BL and 30 min, respectively (P Ͻ 0.05, BL vs. pG z ). SNP produced a dose-dependent decrease in MAP, and L-NAME a dose-dependent increase, as expected (data not shown). pG z at all frequencies induced added pulses visible on the aortic pulse waveform of 1-3 mmHg. These added pulses occurred at peaks and troughs of acceleration of the motion platform (Fig. 1) . The descent of the dicrotic notch pressure cycled downward to upward over periods ranging from 2 to 5 s, but the overall downward descent was maintained throughout the pG z period.
a/b
SNP and pG z caused a dose-dependent increase in a/b. At equivalent mean decrease of aortic pressure of 32% for SNP (3 g/kg dose) and pG z (360 cpm), SNP increased a/b from 1.8 (SD 0.1) BL to 2.2 (SD 0.2) (25% change) (P Ͻ 0.05, BL vs. SNP), whereas pG z of 360 cpm increased from 1.6 (SD 0.2) BL to 3.6 (SD 0.3) (129% change) (P Ͻ 0.05, BL vs. pG z ). The highest SNP (12.5 g/kg) dose studied produced a 49% decrease in MAP, with a corresponding increase of a/b of 58% of BL (P Ͻ 0.05, BL vs. SNP) (Fig. 2) . Compared with pG z of 180 and 600 cpm, pG z of 360 cpm produced the largest increase in a/b from 1.6 (SD 0.2) BL to 3.6 (SD 0.3) (P Ͻ 0.05, 360-cpm pG z vs. 180-and 600-cpm pG z ). pG z of 360 cpm produced an increase in a/b of 129% after 30 min from BL, with a corresponding mean aortic pressure decrease of 37% (Fig. 2) .
L-NAME infusion produced a dose-dependent and significant decrease in a/b (Fig. 2) . The dose of L-NAME (2.5 mg/kg) studied increased MAP to 52% of BL, and correspondingly decreased a/b from BL 1.8 (SD 0.2) to 1.0 (SD 0.1) after L-NAME (P Ͻ 0.05, BL vs. L-NAME).
Effects of pG z on a Dose-Response Curve of L-NAME
L-NAME produced a dose-dependent increase of mean aortic pressure and decrease in a/b in both control and pG z groups. pG z of 180, 360, and 600 cpm all blunted the L-NAME-induced rise of mean aortic pressure. Additionally, all pG z frequencies tested shifted the L-NAME dose response to the right, with a delayed dose-dependent increase of MAP by 2 min compared with control. The rate of MAP increase for control was 9.8 (SD 0.3), for 180-cpm pG z was 7.2 (SD 0.6), for 600-cpm pG z was 6.7 (SD 0.9), and for 360-cpm pG z was 5.6 mmHg/min (SD 1.2) (P Ͻ 0.05, 360-and 600-cpm pG z vs. control). This blunting effect was most pronounced at 360-cpm pG z . Mean aortic pressure rise in control and 180-cpm pG z plateaued at a dose of 2.5 mg/kg of L-NAME. In contrast, this plateau in MAP was reached at higher doses of L-NAME for pG z of 360 and 600 cpm. MAP plateau in pG z of 360 cpm was reached at 4 mg/kg of L-NAME and for pG z of 600 cpm at 3.0 mg/kg (P Ͻ 0.05, 360-and 600-cpm pG z vs. control). Thus the maximum attenuation of MAP increase at each dose of L-NAME was observed with pG z applied at 360 cpm (Fig. 3) .
During the dose response to L-NAME, a/b significantly decreased in control in a dose-dependent manner from 2.1 (SD 0.2) to 1.0 (SD 0.1). In contrast, a/b, in animals receiving pG z of 360 cpm during L-NAME infusion, showed decrease from 3.6 (SD 0.3) and plateaued at 2.0 (SD 0.2) (P Ͻ 0.05, 360-cpm pG z vs. control) (Fig. 4) .
Effects of WM on pG z and of pG z on L-NAME in Presence of WM
WM caused a dose-dependent increase in MAP from 104 (SD 4) to 139 mmHg (SD 5) and drop in a/b of 35% from BL (P Ͻ 0.05, WM vs. BL) in the control group. pG z did not decrease mean aortic pressure or increase a/b, when pG z of 360 cpm was administered together with WM (Fig. 5) . Mean aortic pressure continued to rise in the presence of WM after the start of pG z from 139 mmHg (SD 5) to 151 mmHg (SD 11) (P Ͻ 0.05, pG z vs. BL). pG z did not modify a/b in WM-pretreated animals. The blood pressure blunting effects of pG z on L-NAME were diminished by pretreatment with WM. The WM/ pG z /L-NAME group showed an 84% increase from BL in mean aortic pressure compared with 54% in a group of pG z of 360 cpm and L-NAME alone (P Ͻ 0.05, WM/pG z /L-NAME vs. pG z /L-NAME) (Fig. 6) .
eNOS
A single 1-h exposure to 360-cpm pG z increased protein level of eNOS 70% over control (n ϭ 3 each group) (P Ͻ 0.05, 360-cpm pG z vs. control) (Fig. 7) .
DISCUSSION
The present study demonstrates that, similarly to humans, swine, and sheep, application of pG z to rats produces added low-amplitude pulses to the vasculature and delivers additional pulsatility to the endothelium. This, consequently, induces endothelial-dependent vasodilatation with release of NO into the circulation. The pulses added with pG z generate pulse pressures of 1-3 mmHg, which are identical in magnitude to MAP at corresponding dose of L-NAME in 180-cpm pGz group. *P Ͻ 0.05 vs. MAP at the corresponding dose of L-NAME in control group. Fig. 4 . Effects of 360-cpm pGz pretreatment on a/b during dose response to L-NAME. L-NAME infusion caused a marked decrease in a/b. pGz significantly blunted the L-NAME effect on a/b at all doses of L-NAME. *P Ͻ 0.05 vs. a/b at the corresponding dose of L-NAME in control group. Values are expressed as percent change from baseline with SD (n ϭ 8).
pulse pressures that Hutcheson & Griffith (25) utilized in isolated rat aortic segments to increase NO release from the endothelium. Furthermore, these authors found vasoconstrictive effects with added pulses that had much larger pulse pressures of 16 mmHg and a nonlinear effect of frequency on vasodilatation. They found optimum frequencies for vasodilatation to be between 240 and 360 cpm, with frequencies below and above yielding lower percent vasodilation (25) . Our findings are also consistent with findings from the enhanced external counterpulsation data, wherein timed diastolic pulsations have been shown to improve diastolic endothelial function and NO production (2, 8, 14, 17, 24, 35) . Unlike enhanced external counterpulsation, pG z is not timed to systole or diastole, but its effects on eNOS production and other beneficial endothelial-derived mediators have been established (4, 36, 39, 48) .
Detection of increased NO in the present study was based on a significant rise of the a/b of the aortic pulse, decreased mean aortic pressure, attenuation of L-NAME-induced hypertension along with decreased a/b, and activation of eNOS in the aortic wall. The release of NO from eNOS in rats produced by pG z is consistent with prior observations from our laboratory (1, 4, 6,  39, 42) . SNP, an endothelial-independent NO donor drug, also increased a/b and decreased mean aortic pressure in the rats of the present study, but not to the same extent as pG z when adjustments were made for comparable declines in mean aortic pressure. As expected, inhibition of NO synthesis with L-NAME and WM increased mean aortic pressure and decreased the a/b.
Several investigators have used the relative height of the dicrotic notch as a simple, noninvasive, and sensitive method for NO bioactivity in rabbits using a photoplethysmographic ear pulse, or in humans using either arterial pressures or digital volume pulse (20, 22, 23, 25, 34, 38, 40, 49, 52) . Weinberg et al. (52) have also found a dose-dependent decrease in the relative height of the dicrotic notch or a/b after acetylcholine and SNP, both of which were abolished by L-NAME, and additionally confirmed an NO pathway-mediated effect. Others have found the rise of the a/b in humans after nitroglycerin administration (11, 20, 22, 23, 25, 38, 40, 43) . Our results are consistent and in close agreement with the aforementioned investigators.
The magnitude of descent of the dicrotic notch in our study depended on the frequency of pG z and the duration and dose of the NO donor infused. Application of pG z in normal rats caused a 15-to 20-mmHg decrease in mean aortic pressure after 30 min. These data are similar to those previously reported for anesthetized pigs, where mean arterial systemic blood pressure decreased from 107 mmHg at BL to 88 mmHg during pG z and returned to BL values after pG z was discontinued (4). SNP infusion produced similar changes in mean aortic pressure at doses between 1 and 2.5 g/kg. Despite similar changes in aortic pressure, increases of the a/b differed. pG z caused an 80 -110% increase in a/b, whereas SNP infusion produced only a 20% increase for the same decline in aortic pressure. Since the a/b is a function of arterial wave reflection, the lesser increase of the a/b with SNP compared with pG z can be interpreted as follows: 1) the major site of action of SNP was on large-conduit vessels and pG z on smaller resistance vessels; or 2) pG z also stimulated release of prostacyclin, which provided significant additional vasodilatation to cause the lengthening of the time of wave reflection (4). Nier et al. (42) showed, in rabbits, that the relative height of the dicrotic notch was dose dependently decreased by the cyclooxygenase Fig. 7 . Effect of 360-cpm pGz on aortic protein levels of endothelial NO synthase (eNOS). pGz treatment significantly increased level of eNOS in rat aorta, as indicated by relative positive value of ϩ70% compared with control. Values are expressed as percent change from control with SD (n ϭ 6). *P Ͻ 0.05. Fig. 6 . The effects of pretreatment with WM on pGz ability to blunt L-NAMEinduced changes of MAP (A) and a/b (B). Compared with control (*P Ͻ 0.05 vs. control/L-NAME), the blood pressure blunting effects of pGz on L-NAME were diminished by pretreatment with WM. The WM/pGz/L-NAME group showed a larger increase of arterial pressure and decrease of a/b compared with the pGz/L-NAME group. †P Ͻ 0.05 vs. pGz/L-NAME, 15 g/kg WM, 360-cpm pGz, and 4 mg/kg L-NAME. Values are expressed as percent change from baseline with SD (n ϭ 4).
inhibitor indomethacin. This effect was blocked by L-NAME, suggesting prostaglandin action to be mediated by cross talk with the NO pathway (49). It is not likely that the prostacyclin released with pG z accounts for the difference between pG z and SNP effects on the a/b, since prostacyclin is a much weaker vasodilator. For example, in patients undergoing coronary artery bypass surgery, administration of SNP to lower mean aortic pressure to 10 mmHg increased the a/b only 18% (22) . Thus our results suggest that SNP mainly dilates large conduit vessels, whereas pG z mainly dilates smaller resistance vessels. Additionally, since normal rats were used in these experiments, structural changes in conduit or resistance vessels cannot account for the observed findings.
pG z significantly attenuated the L-NAME-induced increased mean aortic pressure and the concomitant decrease of the a/b. To obtain a similar increase in mean aortic pressure during L-NAME infusion, 360-cpm pG z treated animals required twice the L-NAME dose, presumably due to pG z increased NO production. pG z blunted the dose-dependent vasoconstrictor effect of L-NAME, which was expressed in a slower increase in aortic mean pressure for the same relative dose received by the animal. Decrease in a/b paralleled mean aortic pressure increases during L-NAME infusion (Fig. 6) .
The mechanisms whereby either laminar or pulsatile shear stress increases release of NO into the circulation are complex and multifactorial (12, 53) . In intact animals, laminar shear stress has been thoroughly investigated (19, 33, 51) . However, there has been much less study of pulsatile shear stress alone in intact animals, with the exception of extracorporeal circulation, owing to the paucity of modalities to induce pulsatile shear stress in vivo (31, 54) . Nakano et al. (41) , in an extracorporeal model of pulsatile shear stress, found that eNOS activation is largely caused by tyrosine kinase-sensitive activation. In the present study, one such tyrosine kinase pathway, Akt/PI3K, was investigated by administration of WM that blocks this pathway. This agent blocked the effects of pG z on aortic pressure, abolished the increase of the a/b, and diminished the blunting effect of pG z on action of L-NAME. These findings are consistent with pG z activation of the Akt/PI3K pathway as a stimulus to eNOS activity, the latter via induced pulsations with circumferential stretch on the vascular endothelium. Our results also agree with in vitro endothelial cell culture findings of other investigators, who showed that pulsatile shear stress upregulates eNOS activity via the Akt/PI3K pathway (32, 41, 45, 57) .
From a clinical perspective, pG z has been used in adult human subjects, without side effects. In healthy adults, pG z acutely produced increased NO into the circulation, measured using the a/b and plasma levels of nitrates and nitrites, after 20 pG z sessions over 31 days (21, 46) . pG z chronically applied (20 sessions over 4 wk) to sedentary adults improved vascular endothelial function (as measured by brachial artery flowmediated vasodilatation). Furthermore, in heart failure patients, pG z chronically applied (5 days/wk over 5 wk) increased 6-min walk distance and postischemic flow (a marker of endothelial function) (27) . Our findings of increased eNOS protein expression after 1 h of pG z suggest that pG z upregulates eNOS, which, via NO production, can explain the observed improvement in endothelial function. The optimal frequency observed in our experiments with rats (360 cpm) differs from those used in human subjects (140 cpm). This difference may be related to the differences in intrinsic HR of the two species, but remains to be elucidated.
Optimal release of NO occurred at the 360-cpm setting for pG z , which is a frequency close to the intrinsic rat HR; thus the possibility that resonance might be contributing to our results was considered. There is no information about the rat aorta for added pulses, as occurs with pG z , but a study has been reported in sheep with added pulses produced by intra-aortic balloon counterpulsation on aortic wall energetics and damping. During counterpulsation, diastolic pulses at twice the harmonic of the fundamental with amplitude of ϳ40 mmHg are produced compared with the ϳ3 mmHg of pG z added pulses sweeping through the systolic and diastolic periods. Counterpulsation augmented pulses increase pulse wave velocity, decrease aortic compliance, but did not alter aortic damping. Resonance for the counterpulsation pulses was not measured (18) . In the rat abdominal aorta, weak resonant frequencies were recorded at the second and third harmonic, with the third harmonic significantly greater than the second harmonic of the fundamental (56) . In another study using the rat thoracic aorta, a well-defined resonant peak measured by forced oscillation was recorded at 20 Hz, which is approximately the third harmonic of the rat HR in the present study (9) . The observations that perhaps resonance may play a role during pG z is of interest and perhaps would be better studied under in vitro conditions.
Increase in cardiac output could alter mean fluid shear and affect NO production, as occurs with exercise and as others have reported (15, 16, 28, 31, 37) . We have not directly measured cardiac output in rats in response to pG z . In swine, we have shown a small 11% increase in cardiac output from BL values at a constant pG z frequency of 240 cpm and acceleration of Ϯ3 m/s 2 (5). This small change in cardiac output may be an additional contributor to NO production, but also requires further investigation.
Improving endothelial output via a noninvasive methodology could have significant impact for cardiovascular preconditioning, postconditioning, and planned ischemia-reperfusion events, such as surgery. Future in vitro and in vivo experiments using this model and molecular biology techniques will be useful to further understand the mechanisms whereby increased low-level pulsatility, such as pG z , may confer longterm benefits for endothelial function and tissue repair during and after pathological ischemia-reperfusion injury and cardiovascular events.
